Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01902069 · ClinicalTrials.gov registry record · NA
The Gut-brain Axis in Food Reward and Alcohol Consumption
A NA study of Alcohol Consumption and Impulsivity, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
- 1
- Study location
NCT01902069: Completed NA study of Alcohol Consumption and Impulsivity, sponsored by Yale University.
NCT01902069 is a NA study of Alcohol Consumption and Impulsivity that has completed, run by Yale University. The registered enrollment target is 29 participants, below the 374-participant average among 18 other Alcohol Consumption trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01902069, a NA study of Alcohol Consumption and Impulsivity, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
- 1
- Study location
Study Summary
The aims of this project are to: 1. Determine if 3-weeks dietary supplementation with NOPE-EGCG (PhosphoLEANtm, 85mg NOPE+50mg EGCG per capsule) versus a placebo will improve performance on impulsivity, go/no-go tasks and negative outcome learning in heavy drinkers. 2. Evaluate whether supplementation with NOPE-EGCG versus placebo results in reductions in alcohol consumption. 3. Preliminary data in the rodent model suggests that rats treated with OEA shift preference for lower fat test stimuli. In aim 3 we will Determine if 3-weeks of supplementation with PhosphoLEAN shifts fat preference towards lower fat test puddings.
Primary Outcome
Subject will be asked to sample and rate fatty and sweet flavor stimuli (all made from commercially available ingredients).
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Phospholean
Study Locations (1)
Connecticut
- John B Pierce Laboratory - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-11 |
| Phase | NA |
What the finished NCT01902069 record still lists
NCT01902069 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 374-participant average among 18 other Alcohol Consumption trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Alcohol Consumption appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01902069 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT01902069 about?
NCT01902069 is a clinical study titled "The Gut-brain Axis in Food Reward and Alcohol Consumption". The aims of this project are to: 1. Determine if 3-weeks dietary supplementation with NOPE-EGCG (PhosphoLEANtm, 85mg NOPE+50mg EGCG per capsule) versus a placebo will improve performance on impulsivity, go/no-go tasks and negative outcome learning in heavy drinkers. 2. Evaluate whether supplementat...
What is the current status of trial NCT01902069?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2013-07. Estimated completion is 2014-11.
What conditions does trial NCT01902069 study?
This clinical trial studies the following conditions: Alcohol Consumption, Impulsivity.
What interventions are being tested in trial NCT01902069?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Phospholean (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01902069?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01902069 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Consumption
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01902069's enrollment target sits among peer trials
29 16th of 18 higher than 3 of 18 other Alcohol Consumption trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Consumption trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phosphatidylethanol and Other Ethanol Consumption Markers
RECRUITING · NA
-
Accountability Support Through Peer-Inspired Relationships and Engagement (ASPIRE) Trial
RECRUITING · NA
-
Social Facilitation of Alcohol Effects and Alcohol Misuse in Young Adults
RECRUITING · NA
-
Transcranial Magnetic Stimulation (TMS) Effects Using Magnetoencephalography (MEG) Study
RECRUITING · NA
-
Drinking in Young Adult Duos (DYAD) Study
RECRUITING · NA
-
Engineering an Online STI Prevention Program: RCT
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia